Specific Thrombopoietin Cloned and Sequenced--with Personal Retrospect and Clinical Prospects

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 1995 Jan 1

PMID 7845001

Citations 2

Authors

E Kelemen

Affiliations

Soon will be listed here.

Abstract

Description of some properties, and nomination of human thrombopoietin (TP) had already occurred in Hungary, in 1958. In 1994 five laboratories (three in USA, one in France and one in Japan) independently published clonal purification, sequencing, and chromosomal localization of TP. This breakthrough now approaches therapeutic use in humans.

Citing Articles

Thrombopoietin upregulates nucleolin mRNA and protein in thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

Ito T, Fujihara M, Oda A, Wakamoto S, Yamaguchi M, Komatsu N Mol Cell Biochem. 2003; 247(1-2):75-82.

PMID: 12841634 DOI: 10.1023/a:1024184116764.

An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Cornelissen J, Ploemacher R, Wognum B, Borsboom A, Kluin-Nelemans H, Hagemeijer A J Clin Invest. 1998; 102(5):976-83.

PMID: 9727066 PMC: 508963. DOI: 10.1172/JCI2366.